Ionică F, Pisoschi C, Protasiewicz D, Moța M, Lacatis D, Popescu F. EFFICIENCY OF ATORVASTATIN THERAPY FOR DECREASING THE LEVEL OF HIGHLY SENSITIVE C- REACTIVE PROTEIN (HSCRP) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. RJDNMD [Internet]. 15Jun.2010 [cited 26Aug.2026];17(2). Available from: https://rjdnmd.org/index.php/RJDNMD/article/view/373